Scientific Terms

Ellipses Pharma Cleared by FDA to Open Phase I/II AML Trial

Amgen's Lumakras Sales Increased 58 Percent in Q4 2022

Coeptis Therapeutics, University of Pittsburgh Studying SNAP-CAR Therapy in HER2-Positive Cancers

Aptose Biosciences Begins Expansion Trial of Tuspetinib in TP53, FLT3-Mutant AML

Guardant Health to Integrate Lunit's AI PD-L1 Scoring Algorithm Into Tissue Test Offering

C4 Therapeutics Begins Phase I/II Trial of Protein Degrader in BRAF V600-Mutant Solid Tumors

Daiichi Sankyo, AstraZeneca Begin Phase III Trial of TROP2 Inhibitor, Keytruda in NSCLC

Menarini's Orserdu, Guardant's ctDNA CDx Net FDA Approval for ESR1-Mutated Breast Cancer Patients

Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial

NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients

Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer

Indivumed Sells Biospecimens Service Unit to CRO Crown Bioscience

Verastem Oncology Plans for FDA Submission of Avutometinib-Defactinib Combo in Ovarian Cancer

Geneseeq Nabs CE Marks for Residual Disease and Cancer Early Detection Tests

Ibex Inks Deal With AstraZeneca, Daiichi Sankyo to Develop AI-Based HER2 Scoring

ImmPact Bio to Begin Phase I/II Trial of Bispecific CAR T-Cell Therapy in Aggressive Lymphoma